Empowering dialysis users and caregivers
Search for dialysis centres here
Log in to explore the world's most comprehensive database of dialysis centres for free!
Professional dialysis recruitment| KAI Pharmaceuticals to begin study on secondary hyperparathyroidism in ESRD ... - NephrOnline |
 |
 |
|
NephrOnline KAI Pharmaceuticals Inc. announced enrollment of the first patients in a Phase 2 study of KAI-4169, a pharmaceutical agent being tested for the treatment of secondary hyperparathyroidism (SHPT) in end-stage renal disease patients. |
